Dianthus Therapeutics Inc (DNTH)
$82.38 -0.39% Close Oct 30, 2026 Live
Dianthus Therapeutics stock today
Dianthus Therapeutics closed at $82.38 on October 30, 2026, down 0.39% on the day. Over the past year it returned +144.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $4.50 billion.
$50.00$75.00$100.00
NovJan 2026MarMayJulSep
| Period | DNTH | S&P 500 (SPY) |
|---|---|---|
| 1 month | -6.4% | -0.9% |
| 3 months | -26.9% | +2.1% |
| Year to date | +99.9% | +11.7% |
| 1 year | +144.2% | +12.4% |
| 3 years | +588.2% | +88.5% |
Key statistics
- Market value
- $4.50B
- 52-week range
- $33.20 to $115.96
- Next report
- Nov 5, 2026 (estimated)
About Dianthus Therapeutics
Dianthus Therapeutics is a biopharmaceutical company developing therapeutic treatments for immune and inflammatory diseases.
Sector: Health Care
More on Dianthus Therapeutics
- Financials: revenue, earnings and segmentsRevenue -67% in the year to Dec 2025
- Returns: what $1,000 became$1,000 three years ago is $6,882 today
No forecast, no recommendation. This page describes Dianthus Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.